Concepedia

Frédérique Chaperon

FC

Statistics

Publications

16

Citations

2.1K

H-Index

16

Active since

1996

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Inserm

Sorbonne Université

Pitié-Salpêtrière Hospital

Frédérique Chaperon is an author at Novartis (Switzerland) specializing in neuroscience, pharmacology, and neuropharmacology.

Publications per year

1996–2023

16

Publications

16

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

M. Arnone, Jeanne Maruani, Frédérique Chaperon et al. · Psychopharmacology · 1997 · 595 citations

, , +13

Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects

Rainer Rupprecht, Gerhard Rammes, Daniela Eser et al. · Science · 2009 · 321 citations

, , +14

Involvement of central cannabinoid (CB 1 ) receptors in the establishment of place conditioning in rats

Frédérique Chaperon, Philippe Soubrié, Alain Puech et al. · Psychopharmacology · 1998 · 278 citations

, , +14

Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines

John F. Cryan, Peter H. Kelly, Frédérique Chaperon et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 206 citations

, , +16

The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain

Dominik Feuerbach, Kurt Lingenhoehl, Hans-Rudolf Olpe et al. · Neuropharmacology · 2008 · 127 citations

, , +14

1–5 of 16